Aurobindo Pharma has received the tentative approval to manufacture and market Losartan Potassium tablets in the strengths of 25 mg, 50 mg and 100 mg from the US FDA. This is its 75th ANDA approval from US FDA.
Losartan Potassium tablets are the generic equivalent of Merck Research Laboratories Cozaar tablets and falls in the anti hypertensive segment. The branded sales of Losartan range of products was US$ 1235 million for the year ended December 2007 according to Merck financial disclosures.